ICICaReMe Investigators Forum

Today, the Department of Internal Medicine participated in the ICaReMe Investigators Forum organized by AstraZeneca Kazakhstan at the Novotel Hotel in Almaty.

The meeting highlighted the achievements of the registry, analysis of collected data, publication outcomes, and future development plans for ICaReMe in Kazakhstan.

Special appreciation was expressed by the registry leadership for the significant contribution to patient enrollment and high-quality data collection involving patients with hypertension, diabetes mellitus, heart failure, and chronic kidney disease.

Professor A.B. Sugraliyev delivered presentations on “The First ICaReMe Registry Data in Kazakhstan” and “A Novel Antihypertensive Agent: Aldosterone Synthase Inhibitor.”

Recognition certificates were awarded to Professor Sh.B. Zhangelova, Associate Professor A.Kh. Isabekova, and Associate Professor G.T. Aimakhanova for excellence in clinical data management, adherence to Good Clinical Practice standards, and contribution to advancing healthcare innovation.

We sincerely thank AstraZeneca Kazakhstan for the productive collaboration and exciting plans for continued partnership through 2030.